Canine Chronic Kidney Disease: IRIS Guidelines Overview

UNDERSTANDING CHRONIC KIDNEY DISEASE IN DOGS

Chronic kidney disease, often abbreviated as CKD, is an irreversible, progressive condition characterized by a gradual loss of kidney function over time. In healthy dogs, the kidneys perform several vital tasks, including filtering waste products from the bloodstream, conserving water, maintaining electrolyte balance, and supporting overall systemic health. When kidney tissue is damaged by toxins, infections, immune-mediated conditions, or progressive wear, the remaining working units of the kidney, called nephrons, must work harder to compensate. While this compensatory mechanism can keep a dog stable for a period, it eventually places excessive strain on the remaining tissue, leading to persistent inflammation, scar tissue formation, and a progressive decline in kidney performance.

As kidney function decreases, metabolic waste products such as creatinine, urea nitrogen, and other uremic compounds accumulate in the blood. This accumulation can lead to clinical signs including increased thirst, increased urination, poor appetite, weight loss, lethargy, bad breath, and vomiting. Because managing this condition requires structured evaluation and ongoing monitoring, veterinary specialists rely on standardized protocols developed by the International Renal Interest Society.

WHAT IS THE INTERNATIONAL RENAL INTEREST SOCIETY?

The International Renal Interest Society, widely known as IRIS, is an independent organization established in the late 1990s. Composed of board members and veterinary nephrology experts from around the world, IRIS works to advance the veterinary profession's approach to small animal kidney disease. One of its primary achievements is the creation of evidence-based guidelines for staging chronic kidney disease and grading acute kidney injury in dogs and cats.

The IRIS staging system provides a universal language for veterinary practitioners. By classifying dogs into specific disease stages and sub-stages, veterinarians can better evaluate patient prognosis, select appropriate individualized therapies, track disease progression over time, and communicate clearly with dog owners.

DIAGNOSIS MUST PRECEDE STAGING

A critical principle emphasized by IRIS is that the staging system is not used to initially diagnose kidney disease. Staging is performed only after a definitive diagnosis of chronic kidney disease has already been established in a stable patient.

Veterinarians arrive at a diagnosis of chronic kidney disease by integrating a dog's complete medical history, thorough physical examination findings, blood tests, urinalysis, and diagnostic imaging such as ultrasound or radiographs. When indicated, kidney biopsies may also be evaluated. A single abnormal lab result, such as an isolated elevation in blood waste markers, is not enough to confirm chronic kidney disease. Once the patient is well-hydrated, clinically stable, and confirmed to have chronic kidney changes, the IRIS staging criteria are applied.

THE FOUR IRIS STAGES OF CANINE CKD

The initial stage assignment is based primarily on fasting blood levels of two key waste markers: serum creatinine and symmetric dimethylarginine, commonly known as SDMA. To ensure accuracy, IRIS recommends evaluating these values on at least two separate occasions in a hydrated, stable patient.

Creatinine is a natural byproduct of normal muscle breakdown that is filtered out by healthy kidneys. SDMA is an amino acid derivative that serves as a sensitive surrogate marker of kidney filtration rate. Because SDMA is less influenced by changes in lean muscle mass than creatinine, it can often reveal kidney changes earlier.

STAGE 1: NON-AZOTEMIC KIDNEY DISEASE

In Stage 1, a dog has confirmed underlying kidney damage, but the kidneys are still able to filter blood well enough that waste products have not built up significantly. In dogs, blood creatinine remains below 1.4 mg/dL (less than 125 micromoles per liter), and SDMA is below 18 micrograms per deciliter, though a persistent SDMA elevation above 14 micrograms per deciliter can help identify early disease.

Dogs in Stage 1 typically show no obvious clinical signs of illness. Evidence of kidney damage is instead detected through other diagnostic findings, such as persistent protein in the urine, abnormal kidney shape or texture on imaging, abnormal kidney biopsy results, or a steady upward trend in blood markers over serial tests.

STAGE 2: MILD RENAL AZOTEMIA

In Stage 2, mild azotemia is present, meaning there is a mild accumulation of nitrogenous waste in the bloodstream. For dogs, blood creatinine measures between 1.4 and 2.8 mg/dL (125 to 250 micromoles per liter), and SDMA measures between 18 and 35 micrograms per deciliter.

Clinical signs in Stage 2 dogs are often mild or even absent, though observant owners may notice mild increases in water intake or slightly larger volumes of urine. The IRIS Board expanded Stage 2 for dogs to better capture this transitional phase of the disease.

STAGE 3: MODERATE RENAL AZOTEMIA

Stage 3 represents moderate kidney dysfunction. Dogs in this stage have blood creatinine levels between 2.9 and 5.0 mg/dL (251 to 440 micromoles per liter) and SDMA levels between 36 and 54 micrograms per deciliter.

In Stage 3, signs outside the kidneys become much more apparent. Dogs may experience weight loss, reduced appetite, episodes of vomiting, dehydration, and decreased energy. The extent of these systemic signs varies; a dog with minimal outward signs may be considered early in Stage 3, while a dog with significant symptoms may be classified in late Stage 3.

STAGE 4: SEVERE RENAL AZOTEMIA

Stage 4 is characterized by severe kidney dysfunction. Blood creatinine rises above 5.0 mg/dL (greater than 440 micromoles per liter), and SDMA exceeds 54 micrograms per deciliter.

Dogs in Stage 4 face a high risk of severe clinical complications, pronounced lethargy, severe appetite loss, gastrointestinal ulceration, and uremic crises. Managing dogs in Stage 4 focuses heavily on supporting comfort and maintaining quality of life.

HOW VETERINARIANS HANDLE DISCREPANCIES BETWEEN TEST RESULTS

Sometimes a dog's creatinine and SDMA values suggest two different IRIS stages. For instance, a dog with significant muscle wasting might have a low creatinine level because of reduced muscle mass, while their SDMA level is markedly elevated.

IRIS guidelines provide clear instructions for resolving these discrepancies. If a dog's blood SDMA is persistently elevated into the threshold of a higher stage upon retesting two to four weeks later, the veterinarian will generally stage and treat the dog according to the higher stage indicated by the SDMA value. This ensures the dog receives appropriate supportive care without delay.

SUB-STAGING: PROTEINURIA AND BLOOD PRESSURE

Assigning a primary stage from 1 to 4 is only the first part of the IRIS system. To create a truly comprehensive picture, veterinarians also assign sub-stages based on two crucial parameters: protein loss in the urine and systemic blood pressure.

SUB-STAGING BASED ON PROTEINURIA

Healthy kidney filters prevent large protein molecules from leaking into the urine. When kidney filters are inflamed or damaged, proteins such as albumin escape into the urine, a condition known as proteinuria. Proteinuria can cause further progressive injury to the kidney tubules.

Veterinarians measure this using the Urine Protein-to-Creatinine (UPC) ratio. In dogs, the sub-stages are defined as:

Nonproteinuric: UPC less than 0.2

Borderline proteinuric: UPC between 0.2 and 0.5

Proteinuric: UPC greater than 0.5

SUB-STAGING BASED ON BLOOD PRESSURE

The kidneys play a central role in blood pressure regulation, and kidney disease frequently leads to systemic hypertension, or high blood pressure. High blood pressure can cause further injury to the kidneys, eyes, brain, and heart.

Systolic blood pressure measurements are classified into the following sub-stages:

Normotensive: Systolic blood pressure less than 140 mm Hg

Prehypertensive: Systolic blood pressure between 140 and 159 mm Hg

Hypertensive: Systolic blood pressure between 160 and 179 mm Hg

Severely hypertensive: Systolic blood pressure of 180 mm Hg or greater

IRIS TREATMENT RECOMMENDATIONS ACROSS STAGES

Treating canine chronic kidney disease is never a one-size-fits-all approach. IRIS provides treatment recommendations that serve as logical starting points, which your veterinarian will customize for your dog's unique needs.

In general, therapeutic goals fall into two broad categories

First, treatments that slow the progression of kidney disease and preserve remaining kidney function for as long as possible.

Second, treatments that manage outward clinical signs and support your dog's daily quality of life.

In early disease (Stages 1 and 2), clinical signs are usually minimal, so therapy focuses primarily on slowing disease progression. This often involves managing proteinuria, controlling blood pressure, adjusting dietary intake, and protecting the kidneys from secondary damage.

In advanced disease (Stages 3 and 4), extra-renal signs become more pronounced. While slowing progression remains desirable, the primary clinical focus shifts toward maintaining hydration, supporting appetite, preventing nausea, managing gastrointestinal disturbances, and ensuring comfort.

Because some medications used in kidney management are tailored based on clinical experience rather than uniform official licensing across all regions, your veterinarian will always perform a careful risk-versus-benefit assessment before prescribing any therapy. Your veterinarian will determine the correct dose and monitoring schedule for your pet.

WHEN TO CALL YOUR VET

Dogs with chronic kidney disease require consistent, long-term monitoring. You should contact your veterinarian if you observe any changes in your dog's daily routine, including a sudden increase or decrease in water intake, changes in urination frequency or volume, reduced appetite, sudden weight loss, vomiting, bad breath, pale gums, weakness, or changes in vision. Regular veterinary rechecks, blood pressure assessments, and repeat blood and urine testing are vital to ensure your dog's management plan adapts alongside their changing needs.